# Advancing Validated Drug Targets for Substance Use Disorders (R41/R42 - Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/rfa-da-22-018-advancing-validated-drug-targets-for-substance-use-disorders/  
Official notice: https://www.grants.gov/search-results-detail/334980

> National Institutes of Health offered grants to small businesses. Applications closed on February 18, 2022.

| Field | Value |
|---|---|
| Opportunity number | RFA-DA-22-018 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | February 18, 2022 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.279 |

## Who can apply

- Small businesses

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

## What the grant funds

This Funding Opportunity Announcement (FOA) solicits grant applications from small business concerns (SBCs) to continue research projects with robustly validated targets for Substance Use Disorders (SUDs). This FOA will provide funding for projects entering at either assay development (AD), lead identification (LI), lead optimization (LO), or preclinical development (PCD) stages to allow for the ultimate goal of successfully completing Investigational New Drug-enabling activities.

## Questions people ask

### Is RFA-DA-22-018 still open?

No. It closed on February 18, 2022.

### Who can apply for Advancing Validated Drug Targets for Substance Use Disorders (R41/R42 - Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Advancing Validated Drug Targets for Substance Use Disorders (R41/R42 - Clinical Trial Not Allowed)?

Closed February 18, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under RFA-DA-22-018?

NIH RePORTER lists 2 projects funded under RFA-DA-22-018 in fiscal 2022 to 2023, at 2 institutions. The most were at Phoenix Pharmalabs, Inc., Eleutheria Pharmaceuticals LLC.

### Who has won Drug Use and Addiction Research Programs grants before?

The largest recipients over five fiscal years were Yale Univ, The Johns Hopkins University, University of California, San Diego. The program made 5,071 awards worth $7.3 billion in that time.